WMV-35056-41298
4 vaccinations
2 coded responses
42 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
XQN-24703-34496
Child or adolescent in my care · Female · 2021-11-24
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Pfizer-BioNTech
- 2021-04-07
- 2021-04-08
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-14
- 2021-04-21
-
2021-04-28
Dose 2 — Pfizer-BioNTech
- 2021-04-28
-
2021-04-29
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-05-26
- 2021-06-02
- 2021-06-09
- 2021-07-28
- 2021-10-27
-
2021-11-22
Dose 3 — Pfizer-BioNTech
- 2021-11-24
- 2021-11-26
- 2021-11-27
- 2021-11-28
- 2021-11-29
- 2021-12-06
- 2021-12-13
- 2021-12-20
- 2021-12-27
-
2022-01-03
Survey response — day 42, dose 3MedDRA: Cough, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Cough, feverMedDRA releases: 2024-11 · check-in free text available
- 2022-02-21
- 2022-05-23
-
2022-09-13
Dose 4 — Moderna
- 2022-10-10
- 2022-10-11
- 2022-10-18
- 2022-10-25
-
2022-12-13
Survey response — 3 months, dose 4MedDRA: Brain fog, Dyspnoea, Heart rate increased — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Shortness of breath, brain fog, rapid pulseMedDRA releases: 2024-11 · check-in free text available
-
2022-12-13
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
-
2022-12-14
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2021-11-22 | Pfizer-BioNTech | No |
| 4 | 2022-09-13 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-13 | Successful 2022-12-14 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 10 — day 42, dose 3
Symptoms: Cough, fever
Release 12 — 3 months, dose 4
Symptoms: Shortness of breath, brain fog, rapid pulse
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Brain fog | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release